The role of distribution as a determinant of central anticholinergic specificity in a series of oxotremorine analogs.
D000475:Alkenes / Q000378:metabolism / Q000494:pharmacology; D000480:Alkynes / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000378:metabolism*; D002849:Chromatography, Gas; D004336:Drug Antagonism; D008297:Male; D051379:Mice; D010276:Parasympatholytics / Q000378:metabolism* / Q000494:pharmacology; D011199:Potentiometry; D011759:Pyrrolidines / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology; D011760:Pyrrolidinones / Q000037:antagonists & inhibitors / Q000378:metabolism*; D013388:Succinimides / Q000378:metabolism / Q000494:pharmacology; D014202:Tremor / Q000139:chemically induced
D000475:Alkenes; D000480:Alkynes; D010276:Parasympatholytics; D011759:Pyrrolidines; D011760:Pyrrolidinones; D013388:Succinimides